Clover Health [CLOV] vs CVS Health [CVS] Detailed Stock Comparison

Clover Health Investments Corp.

NASDAQ
Loading...

CVS Health Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Clover Health Investments Corp. wins in 1 metrics, CVS Health Corporation wins in 17 metrics, with 1 ties. CVS Health Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Clover Health Investments Corp. CVS Health Corporation Better
P/E Ratio (TTM) -14.09 55.65 CVS Health Corporation
Price-to-Book Ratio 4.20 1.31 CVS Health Corporation
Debt-to-Equity Ratio 0.00 106.06 Tie
PEG Ratio -0.09 0.72 CVS Health Corporation
EV/EBITDA -13.96 11.48 CVS Health Corporation
Profit Margin (TTM) -4.45% 0.44% CVS Health Corporation
Operating Margin (TTM) -10.11% 1.57% CVS Health Corporation
EBITDA Margin (TTM) N/A 1.57% N/A
Return on Equity -26.33% 2.29% CVS Health Corporation
Return on Assets (TTM) -9.53% 2.47% CVS Health Corporation
Free Cash Flow (TTM) $-68.98M $7.81B CVS Health Corporation
Dividend Yield N/A 3.23% N/A
1-Year Return 26.75% 42.07% CVS Health Corporation
Price-to-Sales Ratio (TTM) 0.68 0.25 CVS Health Corporation
Enterprise Value $1.19B $167.94B CVS Health Corporation
EV/Revenue Ratio 0.62 0.42 CVS Health Corporation
Gross Profit Margin (TTM) 15.22% 12.84% Clover Health Investments Corp.
Revenue per Share (TTM) $4 $316 CVS Health Corporation
Earnings per Share (Diluted) $-0.17 $1.39 CVS Health Corporation
Beta (Stock Volatility) 2.25 0.51 CVS Health Corporation
Short % of Float 9.37% 1.56% CVS Health Corporation

Clover Health Investments Corp. vs CVS Health Corporation Stock Performance Analysis

Loading Price Chart...

CLOV
CVS

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Clover Health Investments Corp.-2.14%3.32%40.75%82.84%49.80%54.77%
CVS Health Corporation2.09%-1.36%9.13%9.60%15.31%11.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Clover Health Investments Corp.26.75%352.27%-55.78%-60.98%-60.98%-60.98%
CVS Health Corporation42.07%29.99%5.22%-5.47%139.61%211.15%

Performance & Financial Health Analysis: Clover Health Investments Corp. vs CVS Health Corporation

MetricCLOVCVS
Market Information
Market Cap i$1.26B$101.07B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i5,270,2757,440,168
90 Day Avg. Volume i5,678,4687,575,109
Last Close$3.65$91.37
52 Week Range$1.58 - $4.23$58.50 - $98.43
% from 52W High-13.71%-7.17%
All-Time High$28.85 (Jun 07, 2021)$113.65 (Jul 27, 2015)
% from All-Time High-87.35%-19.60%
Growth Metrics
Quarterly Revenue Growth0.45%0.08%
Quarterly Earnings Growth0.45%0.79%
Financial Health
Profit Margin (TTM) i-0.04%0.00%
Operating Margin (TTM) i-0.10%0.02%
Return on Equity (TTM) i-0.26%0.02%
Debt to Equity (MRQ) i0.00106.06
Cash & Liquidity
Book Value per Share (MRQ)$0.60$59.18
Cash per Share (MRQ)$0.23$8.33
Operating Cash Flow (TTM) i$-66,934,000$10.64B
Levered Free Cash Flow (TTM) i$-35,821,624$5.93B
Dividends
Last 12-Month Dividend Yield iN/A3.23%
Last 12-Month Dividend iN/A$2.68

Valuation & Enterprise Metrics Analysis: Clover Health Investments Corp. vs CVS Health Corporation

MetricCLOV (Apr 24, 2026)CVS (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-14.0955.65
Forward P/E i27.789.45
PEG Ratio i-0.090.72
Price to Sales (TTM) i0.680.25
Price to Book (MRQ) i4.201.31
Market Capitalization
Market Capitalization i$1.26B$101.07B
Enterprise Value i$1.19B$167.94B
Enterprise Value Metrics
Enterprise to Revenue i0.620.42
Enterprise to EBITDA i-13.9611.48
Risk & Other Metrics
Beta i2.250.51
Book Value per Share (MRQ) i$0.60$59.18

Financial Statements Comparison: Clover Health Investments Corp. vs CVS Health Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCLOV (2025)CVS (2025)
Revenue/Sales i1.92B402.07B
Cost of Goods Sold i1.57B346.71B
COGS % of Revenue i81.5%86.2%
Gross Profit i355.90M55.36B
Gross Margin i18.5%13.8%
Research & Development iN/AN/A
Operating Income (EBIT) i-85.53M10.39B
Operating Margin i-4.4%2.6%
EBITDA i-83.84M15.10B
EBITDA Margin i-4.4%3.8%
Pre-Tax Income i-85.55M2.14B
Pre-Tax Income % of Revenue i-4.4%0.5%
Income Tax iN/A408.00M
Income Tax % of Revenue i0.0%0.1%
Net Income (Profit) i-85.55M1.73B
Profit Margin i-4.4%0.4%

Balance Sheet & Liquidity Metrics

MetricCLOV (2025)CVS (2025)
Cash & Equivalents i78.30M8.45B
Total Current Assets i307.86M74.71B
Total Current Assets % of Revenue i16.0%18.6%
Total Current Liabilities i208.82M88.69B
Total Current Liabilities % of Revenue i10.9%22.1%
Long-Term Debt iN/A74.15B
Long-Term Debt % of Revenue i0.0%18.4%
Total Shareholders Equity i308.70M75.38B
Retained Earnings i-2.29B61.20B
Retained Earnings % of Revenue i-118.9%15.2%
Property, Plant & Equipment i113,00014.97B

Cash Flow Statement Comparison

MetricCLOV (2025)CVS (2025)
Operating Cash Flow i-57.89M5.15B
Operating Cash Flow % of Revenue i-3.0%1.3%
Capital Expenditures i-2.04M-2.83B
Free Cash Flow i-68.98M7.81B
FCF Margin i-3.6%1.9%
Debt Repayment iN/A-5.75B
Common Stock Repurchase i-55.20M0

Short Interest & Institutional Ownership Analysis

MetricCLOVCVS
Shares Short i39.12M19.89M
Short Ratio i6.962.56
Short % of Float i9.37%1.56%
Shares Outstanding i519.04M1.27B
Float Shares i406.66M1.27B
% Held by Insiders i3.25%0.07%
% Held by Institutions i29.71%90.07%
% Held by Public i67.04%9.86%

Dividend Analysis & Yield Comparison: Clover Health Investments Corp. vs CVS Health Corporation

MetricCLOVCVS
Last 12-Month Dividend iN/A$2.68
Last 12-Month Dividend Yield iN/A3.23%
3-Year Avg Annual Dividend iN/A$2.61
3-Year Avg Dividend Yield iN/A0.97%
3-Year Total Dividends iN/A$7.83
Ex-Dividend DateN/AJan 22, 2026